Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries
- PMID: 22905296
- PMCID: PMC3421137
- DOI: 10.4330/wjc.v4.i7.234
Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries
Abstract
Due to recent population emigration movements, an epidemic of Chagas disease is currently menacing most developed countries. The authors report the case of a 53-year-old Brazilian woman living in Europe for the last 10 years who developed heart failure symptoms, having a previous symptomatic sinus node disease with a pacemaker implant at age of 40 years. The diagnosis was based on serology and myocardial biopsy and the patient was treated with nifurtimox. The authors emphasize the need of a high level of suspicion in patients with suggestive epidemiology and the need of populational screening of specific high risk groups. New treatment options are also discussed.
Keywords: Benznidazole; Chagas cardiomyopathy; Chagas disease; Dysrhythmia; Emigration; Nifurtimox; Non-endemic countries.
Figures


Similar articles
-
[Chagas disease].Rev Med Interne. 2009 Aug;30(8):686-95. doi: 10.1016/j.revmed.2008.11.010. Epub 2009 Feb 6. Rev Med Interne. 2009. PMID: 19201068 French.
-
Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.J Antimicrob Chemother. 2020 Mar 1;75(3):690-696. doi: 10.1093/jac/dkz473. J Antimicrob Chemother. 2020. PMID: 31754690 Free PMC article.
-
Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.Rev Soc Bras Med Trop. 2007 Jan-Feb;40(1):1-10. doi: 10.1590/s0037-86822007000100001. Rev Soc Bras Med Trop. 2007. PMID: 17486245
-
Chagas disease and transfusion medicine: a perspective from non-endemic countries.Blood Transfus. 2015 Oct;13(4):540-50. doi: 10.2450/2015.0040-15. Blood Transfus. 2015. PMID: 26513769 Free PMC article. Review.
-
First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.J Pharm Sci. 2012 Mar;101(3):888-94. doi: 10.1002/jps.23010. Epub 2011 Dec 12. J Pharm Sci. 2012. PMID: 22161779 Review.
Cited by
-
PREVALENCE OF CHAGAS DISEASE AMONG BLOOD DONOR CANDIDATES IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL.Rev Inst Med Trop Sao Paulo. 2015 Dec;57(6):461-5. doi: 10.1590/S0036-46652015000600001. Rev Inst Med Trop Sao Paulo. 2015. PMID: 27049698 Free PMC article.
-
Epidemiology of Chagas disease in Europe: many calculations, little knowledge.Clin Res Cardiol. 2014 Jan;103(1):1-10. doi: 10.1007/s00392-013-0613-y. Epub 2013 Aug 29. Clin Res Cardiol. 2014. PMID: 23989652 Review.
References
-
- Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, Seixas J, Van Gool T, Canavate C, Flores-Chavez M, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16:pii 19968. - PubMed
-
- Available from: www.who.int/neglected_diseases/2010report/en/
-
- Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388–1402. - PubMed
-
- Telleria J, Tibayrenc M. American Trypanosomiasis: Chagas Disease One Hundred Years of Research (Elsevier Insights). 1st ed. Amsterdam : Elsevier. 2010:531–532.
LinkOut - more resources
Full Text Sources